Zydus Lifesciences gets WHO INN approval for 'Usnoflast' as recommended name for ZYIL1 Ruchika Sharma2 April 2024 1:30 PM ISTUsnoflast (ZYIL1) is a novel oral small molecule NLRP3 inhibitor discovered at Zydus.
USFDA inspection: Zydus Lifesciences gets 4 observations for Ahmedabad plant Ruchika Sharma28 March 2024 12:30 PM ISTAhmedabad: Zydus Lifesciences has announced that the Company has received four observations from the U.S. Food and Drug Administration (USFDA) at...
Zydus Lifesciences receives tentative approval from USFDA for Letermovir Tablets Ruchika Sharma24 March 2024 2:30 PM ISTLetermovir tablets are used to prevent disease caused by a virus called cytomegalovirus in people who have received a bone marrow transplant or kidney...
Zydus Lifesciences gets USFDA okay for Finasteride and Tadalafil Capsules Susmita Roy18 March 2024 11:52 AM ISTTadalafil is used to treat benign prostatic hyperplasia.
Zydus Lifesciences bags USFDA tentative nod for Edaravone Injection to treat amyotrophic lateral sclerosis Susmita Roy15 March 2024 11:49 AM ISTEdaravone is used to treat a certain type of nerve disease called amyotrophic lateral sclerosis.
Zydus Lifesciences wins USFDA nod for Chlorpromazine Hydrochloride Injection for certain mental disorders Susmita Roy14 March 2024 4:00 PM ISTThe drug will be manufactured at the group's injectable manufacturing facility at Jarod, near Vadodara (India).
Zydus Lifesciences gets USFDA EIR for API Ahmedabad facility Ruchika Sharma11 March 2024 11:45 AM ISTAhmedabad: Zydus Lifesciences has announced that the Company has received the EIR report from the United States Food and Drug Administration...
USFDA gives nod for commercial production at Zydus Ahmedabad API unit Ruchika Sharma7 March 2024 5:07 PM ISTAhmedabad: Pharma major Zydus Lifesciences has announced that the company has received Post Application Action Letter from the US Food and...
Zydus Lifesciences aims to launch first new drug in US by early 2026 Ruchika Sharma28 Feb 2024 4:30 PM ISTAhmedabad: India's Zydus Lifesciences is aiming to launch its first new drug in the United States by early 2026, looking to tap into the...
Zydus Lifesciences bags WHO prequalification nod for Miltefosine formulation, API to treat Leishmaniasis Ruchika Sharma26 Feb 2024 12:21 PM ISTAhmedabad: Zydus Lifesciences Limited has announced that the Company has received the World Health Organisation (WHO) prequalification approval ...
Zydus Lifesciences incorporates wholly owned subsidiary company in UAE Ruchika Sharma23 Feb 2024 1:30 PM ISTAhmedabad: Zydus Lifesciences has incorporated a wholly owned subsidiary company in the name of Zydus Lifesciences Global FZE. in Jebel...
Zydus Lifesciences secures USFDA okay for angina drug Isosorbide Mononitrate ER Ruchika Sharma16 Feb 2024 3:52 PM ISTAhmedabad: Pharma major Zydus Lifesciences Limited has announced that the Company has received final approval from the United States Food...
